These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19051778)

  • 1. New technique monitors patients with NSCLC.
    McBride D
    ONS Connect; 2008 Nov; 23(11):25. PubMed ID: 19051778
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic markers for stage I non-small cell lung cancer.
    Ohara G; Satoh H; Hizawa N
    Lung Cancer; 2008 Jan; 59(1):137. PubMed ID: 17996327
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers for stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N
    Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061
    [No Abstract]   [Full Text] [Related]  

  • 6. Invited commentary.
    D'Amico T
    Ann Thorac Surg; 2007 Jan; 83(1):221-2. PubMed ID: 17184667
    [No Abstract]   [Full Text] [Related]  

  • 7. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
    Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
    J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.
    Masago K; Fujita S; Kim YH; Ichikawa M; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Mio T; Mishima M
    Cancer Genet Cytogenet; 2009 Dec; 195(2):179-82. PubMed ID: 19963121
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
    Gao W; Liu L; Lu X; Shu Y
    Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
    [No Abstract]   [Full Text] [Related]  

  • 11. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
    Bubanović G; Pavićević R; Franjević A
    Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
    Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
    Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer.
    de Castro J; Rodríguez MC; Martínez-Zorzano VS; Llanillo M; Sánchez-Yagüe J
    Exp Mol Pathol; 2009 Dec; 87(3):226-33. PubMed ID: 19733167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
    Kancha RK; von Bubnoff N; Peschel C; Duyster J
    Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
    Pérez-Soler R
    Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
    Inoue A; Kobayashi K; Usui K; Maemondo M; Okinaga S; Mikami I; Ando M; Yamazaki K; Saijo Y; Gemma A; Miyazawa H; Tanaka T; Ikebuchi K; Nukiwa T; Morita S; Hagiwara K;
    J Clin Oncol; 2009 Mar; 27(9):1394-400. PubMed ID: 19224850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
    Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
    Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
    Sangha R; Lara PN; Mack PC; Gandara DR
    Curr Opin Oncol; 2009 Mar; 21(2):116-23. PubMed ID: 19532012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.